Pilot of a New Cognitive Assessment Tool for Detecting Dementia in the Migrant Somali Population
NCT ID: NCT05163821
Last Updated: 2023-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2022-01-08
2023-12-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The investigators want to find out if the tool that they have made to assess memory and thinking in Somali elders ( the 'MSCAT') is acceptable to that community and practical to administer and score.
* The public will benefit from this research because it seeks to enhance reliability of diagnosis of dementia, thus access to support and treatment for people from an ethnic minority group experiencing memory problems.
Background
* The investigators are a group of staff from the Memory Assessment Service in Manchester. There are currently no suitable tests for dementia for people from Somalia.
* Research evidence tells us there are many reasons why the tools that used now are not working. This includes: differences in culture and ways of life that are very different to a British born person who has lived in the UK for all of their life.
* Somali people find out at a later stage if they have dementia resulting in delayed treatment/support.
* This research supports the government's promise to improve the pathway to a diagnosis of dementia for minority groups.
Design and methods
* 10 participants
* The investigators will compare the assessment tool (MSCAT) that the team have developed to the Addenbrookes Cognitive Examination III tool that is typically used.
* Participants will be seen at an agreed location (e.g. home, mosque or GMMH trust site). They will meet a Somali speaking researcher to do both tests on 2 appointments and discuss how they found the tests afterwards.
* The investigators will check participants understanding of the research before they agree to take part. Verbal and written information will be provided.
Public involvement
* The local Somali community helped advise on the creation of the new MSCAT assessment tool.
* The investigators will write project information for participants in Somali and English.
Dissemination of results
• Professional conference presentations and publications
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
Somali migrants in UK, aged over 50.
Manchester Somali Cognitive Assessment Tool
Cognitive screen for dementia
ACE-III Somali Translation
Cognitive screen for dementia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manchester Somali Cognitive Assessment Tool
Cognitive screen for dementia
ACE-III Somali Translation
Cognitive screen for dementia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Greater Manchester Mental Health NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sophie Jeffery
Principal Clinical Psychologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Greater Manchester Mental Health NHS Trust
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
x503s
Identifier Type: -
Identifier Source: org_study_id